AGF U.S. Market Neutral Anti-Beta Fund Reports Insider Buying Trends
The AGF U.S. Market Neutral Anti-Beta Fund (BTAL) shows that 25.7% of its holdings have seen insider buying activity over the past six months. This statistic highlights a pronounced trend among company insiders taking a stake in their own firms.
Marvell Technology Inc: Significant Insider Purchases
Marvell Technology Inc (Symbol: MRVL), constituting -6.58% of the AGF U.S. Market Neutral Anti-Beta Fund (BTAL), has recently seen insider purchases from two of its directors. According to Form 4 filings, the ETF currently holds $-1,019,477 worth of MRVL, ranking it as the #206 largest holding in the fund. Below is a table summarizing the latest insider buying activity for Marvell:
MRVL — Last Trade: $55.64 — Recent Insider Buys:
| Purchase Date | Insider | Title | Shares | Price/Share | Total Value |
|---|---|---|---|---|---|
| 10/14/2024 | Matthew J. Murphy | Chairman of the Board and CEO | 13,000 | $77.63 | $1,009,190 |
| 03/07/2025 | Brad W. Buss | Director | 3,000 | $69.00 | $207,000 |
Charles River Laboratories International Inc: Insider Investments
Charles River Laboratories International Inc. (Symbol: CRL), ranked as the #259 largest holding in the AGF U.S. Market Neutral Anti-Beta Fund (BTAL), has recorded insider buying from two directors, as captured in recent Form 4 filings. The ETF currently holds $-1,365,538 worth of CRL, accounting for approximately -8.81% of the ETF’s total assets as of the latest review. Detailed in the table below is the recent insider buying activity for Charles River Laboratories:
CRL — Last Trade: $140.98 — Recent Insider Buys:
| Purchase Date | Insider | Title | Shares | Price/Share | Total Value |
|---|---|---|---|---|---|
| 02/20/2025 | Birgit Girshick | Corporate Executive VP & COO | 1,514 | $164.63 | $249,250 |
| 02/20/2025 | James C. Foster | Chairman, President and CEO | 6,075 | $165.01 | $1,002,436 |
10 ETFs With Stocks That Insiders Are Buying »
Also See:
CNCE YTD Return
Funds Holding CCNC
SGDM Options Chain
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
